tiprankstipranks
Immunovant (IMVT)
NASDAQ:IMVT
US Market

Immunovant (IMVT) Technical Analysis

Compare
805 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Immunovant’s (IMVT) Moving Averages Convergence Divergence (MACD) indicator is -0.70, suggesting Immunovant is a Sell.
Immunovant’s (IMVT) 20-Day exponential moving average is 20.81, while Immunovant’s (IMVT) share price is $20.6, making it a Sell.
Immunovant’s (IMVT) 50-Day exponential moving average is 22.61, while Immunovant’s (IMVT) share price is $20.6, making it a Sell.

Immunovant (IMVT) Pivot Points

Mar 03, 2025, 06:54 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.32
19.72
19.99
20.39
20.66
21.06
21.33
Fibonacci
19.72
19.98
20.14
20.39
20.65
20.81
21.06
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Immunovant (IMVT) Moving Averages

Mar 03, 2025, 06:54 PM
Period
Simple
Exponential
MA5
20.23Buy
20.37Buy
MA10
20.48Buy
20.41Buy
MA20
20.47Buy
20.81Sell
MA50
22.78Sell
22.61Sell
MA100
25.83Sell
24.68Sell
MA200
27.33Sell
26.58Sell
Immunovant’s (IMVT) 10-Day exponential moving average is 20.41, while Immunovant’s (IMVT) share price is $20.6, making it a Buy.
Immunovant’s (IMVT) 100-Day exponential moving average is 24.68, while Immunovant’s (IMVT) share price is $20.6, making it a Sell.
Immunovant’s (IMVT) stock price is $20.6 and Immunovant’s (IMVT) 50-day simple moving average is 22.78, creating a Sell signal.
Immunovant’s (IMVT) stock price is $20.6 and Immunovant’s (IMVT) 100-day simple moving average is 25.83, creating a Sell signal.
Immunovant’s (IMVT) stock price is $20.6 and Immunovant’s (IMVT) 200-day simple moving average is 27.33, creating a Sell signal.

Immunovant (IMVT) Technical Indicators

Mar 03, 2025, 06:54 PM
Name
Value
Implied Action
RSI (14)
45.21
Neutral
STOCH (9,6)
38.50
Neutral
STOCHRSI (14)
43.22
Neutral
MACD (12,26)
-0.70
Sell
ADX (14)
18.44
Buy
Williams %R
-40.93
Buy
CCI (14)
-13.00
Neutral
ATR (14)
1.01
-
Ultimate Oscillator
34.02
Neutral
ROC
0.93
Buy
Immunovant’s (IMVT) Relative Strength Index (RSI) is 45.21, creating a Neutral signal.
Immunovant’s (IMVT) Trend Strength Indicator (ADX) is 18.44, creating a Buy signal.
Immunovant’s (IMVT) Commodity Channel Index (CCI) is -13.00, creating a Neutral signal.
Immunovant’s (IMVT) Price Rate of Change (ROC) is 0.93, creating a Buy signal.

FAQ

Is IMVT a Buy, Hold, or Sell?
Based on IMVT’s technical indicators, IMVT is a Hold.
    What is IMVT’s RSI (14)?
    IMVT’s RSI (14) is 45.21, which suggests IMVT is a Neutral.
      What is IMVT’s MACD?
      IMVT’s MACD is -0.70, which suggests IMVT is a Sell.
        What is IMVT’s 5-day moving average?
        IMVT’s 5-day moving average is 20.23, which suggests IMVT is a Buy.
          What is IMVT’s 20-day moving average?
          IMVT 20-day moving average is 20.47, which suggests IMVT is a Buy.
            What is IMVT’s 50-day moving average?
            IMVT’s 50-day moving average is 22.78, which suggests IMVT is a Sell.
              What is IMVT’s 200-day moving average?
              IMVT’s 200-day moving average is 27.33, which suggests IMVT is a Sell.
                What is IMVT’s Williams % R (14)?
                IMVT’s Williams % R (14) is -40.93, which suggests IMVT is a Buy.
                  What is IMVT’s CCI (14)?
                  IMVT’s CCI (14) is -13.00, which suggests IMVT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis